Unlike other methods of fracture treatment, the IlluminOss photodynamic bone stabilization system is designed to enable the patient to have immediate joint mobility post procedure without the need for immobilization. Due to the minimally invasive approach, soft tissue injury is virtually eliminated. Having immediate mobility minimizes the potential for tendon adhesions and a tenolysis procedure to remove them, the company said.
IlluminOss Medical is beginning the process of selecting distribution partners in the EU for the IlluminOss photodynamic bone stabilization system.
Bob Rabiner, founder and CEO of IlluminOss Medical, said: “This approval represents a major milestone for IlluminOss and patients in the EU. We believe that our minimally invasive technology will fundamentally improve the treatment of hundreds of thousands of bone fractures by driving much earlier restoration of functionality, improving the durability of orthopedic repairs, decreasing pain and reducing scarring.”